Reuters logo
BRIEF-Sonoma Pharmaceuticals reports qtrly loss per share from continuing operations $ 0.69
June 5, 2017 / 8:12 PM / 3 months ago

BRIEF-Sonoma Pharmaceuticals reports qtrly loss per share from continuing operations $ 0.69

June 5 (Reuters) - Sonoma Pharmaceuticals Inc:

* Sonoma Pharmaceuticals reports financial results for fourth quarter and fiscal year 2017

* Q4 revenue $4.0 million versus $2.6 million

* Qtrly loss per share from continuing operations $ 0.69 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below